Chile nears hantavirus antibody treatment but funding runs out before human trials

Published on 14 May 2026

Lab success still failed to reach patients

Chile researchers developed antibodies that neutralised the deadly Andes hantavirus in lab and animal tests, showing real promise against a rare virus that can spread between people. But the effort stalled before human trials, crushed by limited funding and the disruption of the Covid-19 pandemic.

Antibodies neutralised the Andes hantavirus in lab and animal studies
The approach aimed at a treatment for a rare but potentially contagious virus
Human trials never began due to funding gaps
Covid-19 derailed the project just as it needed momentum

#funding #vaccine research #hantavirus #antibodies #covid pandemic

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

Chile nears hantavirus antibody treatment but funding runs out before human trials

The full experience is on mobile.